Active, Not Recruiting
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404
- Conditions
- Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
- Locations
-
- Research Site Wollongong, New South Wales, Australia
- Research Site Benowa, Queensland, Australia
- Research Site Buderim, Queensland, Australia
- Research Site Greenslopes, Queensland, Australia